AMERICAS DISTRESS DAILY: Purdue Pharma’s Settlement Trial Begins

A multiday trial began Wednesday for bankruptcy court approval of Purdue Pharma’s $7.4 billion opioid liability settlement, which has overwhelming creditor support.

• A prior version was overturned by the US Supreme Court.

In Other News:

• Bankrupt marine animal-park operator Dolphin Co. won approval to sell its St. Augustine, Fla., location to a buyer that will keep the historic oceanarium operating.
• Fossil Group was granted a Chapter 15 recognition order in Texas to recognize its restructuring plan related to its 7% senior notes due 2026. The watchmaker also won UK recognition of the plan.
• New Fortress Energy is delaying its ...